Your browser doesn't support javascript.
loading
Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity.
Thalappil, Sherin; Al-Nesf, Maryam.
  • Thalappil S; Adult Allergy and Immunology Section, Department of Medicine, Hamad Medical Corporation, Doha, Qatar E-mail: SThalappil@hamad.qa.
  • Al-Nesf M; Adult Allergy and Immunology Section, Department of Medicine, Hamad Medical Corporation, Doha, Qatar E-mail: SThalappil@hamad.qa.
Qatar Med J ; 2022(2): 4, 2022.
Article en En | MEDLINE | ID: mdl-35968519
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article